Orion Oyj
Orion Oyj (ORINY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ORINY · as of Jun 9, 2026
Key Statistics
Explore Orion Oyj Data
oriny stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 66.7%
Competitors & Peers
oriny competitorsORINY
ALPMF
ALPMY
CLPBY
GIKLY
OTSKFStock Performance
Full HistoryAbout Orion Oyj
Orion Oyj is a Finnish pharmaceutical company specializing in the creation, production, and commercialization of medicines for both human and animal health, as well as the active components (APIs) ess…
what is orion oyj · oriny stock overview · orion oyj company profile · who is orion oyj ceo · oriny OTC · orion oyj headquarters · orion oyj business segments
About Stock Overview & Key Data
Orion Oyj (ORINY) is a Healthcare company in the Drug Manufacturers - General industry, listed on OTC since Dec 9, 2014. As of the latest trading session, ORINY stock price is $40.63, with a market capitalization of $22.9B. The stock has returned +13.75% over the past 12 months and +10.29% year-to-date.
According to 3 Wall Street analysts, the consensus rating for Orion Oyj stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Orion Oyj reported revenue of $1.9B and net income of $480.6M. For detailed data — including Orion Oyj revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Orion Oyj (ORINY) stock price is $40.63. The stock is traded on OTC under the ticker symbol ORINY. The 52-week range is $30.89 – $42.75.